Integrated Diagnostics (IDHC) Competitors GBX 0.59 0.00 (-0.34%) As of 05/22/2026 11:43 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsBuy This Stock IDHC vs. DXRX, ABDX, GDR, YGEN, and AGLShould you buy Integrated Diagnostics stock or one of its competitors? MarketBeat compares Integrated Diagnostics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Integrated Diagnostics include Diaceutics (DXRX), Abingdon Health (ABDX), genedrive (GDR), Yourgene Health (YGEN), and ANGLE (AGL). These companies are all part of the "diagnostics & research" industry. IDHC vs. DXRXIDHC vs. ABDXIDHC vs. GDRIDHC vs. YGENIDHC vs. AGLHow does Integrated Diagnostics compare to Diaceutics?Diaceutics (LON:DXRX) and Integrated Diagnostics (LON:IDHC) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, valuation, analyst recommendations, institutional ownership and media sentiment. Does the media favor DXRX or IDHC? In the previous week, Diaceutics' average media sentiment score of 0.00 equaled Integrated Diagnostics'average media sentiment score. Company Overall Sentiment Diaceutics Neutral Integrated Diagnostics Neutral Do insiders & institutionals hold more shares of DXRX or IDHC? 32.7% of Diaceutics shares are held by institutional investors. Comparatively, 7.7% of Integrated Diagnostics shares are held by institutional investors. 26.3% of Diaceutics shares are held by company insiders. Comparatively, 28.0% of Integrated Diagnostics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Do analysts prefer DXRX or IDHC? Diaceutics presently has a consensus target price of GBX 193.33, indicating a potential upside of 17.17%. Given Diaceutics' stronger consensus rating and higher possible upside, research analysts clearly believe Diaceutics is more favorable than Integrated Diagnostics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Diaceutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Integrated Diagnostics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has stronger valuation and earnings, DXRX or IDHC? Integrated Diagnostics has higher revenue and earnings than Diaceutics. Diaceutics is trading at a lower price-to-earnings ratio than Integrated Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDiaceutics£34.40M4.06-£2.84M-£1.80N/AIntegrated Diagnostics£8.35B0.00£4.01T£217.000.00 Is DXRX or IDHC more profitable? Integrated Diagnostics has a net margin of 17.46% compared to Diaceutics' net margin of -4.42%. Integrated Diagnostics' return on equity of 42.26% beat Diaceutics' return on equity.Company Net Margins Return on Equity Return on Assets Diaceutics-4.42% -3.94% -6.06% Integrated Diagnostics 17.46%42.26%9.69% Which has more risk and volatility, DXRX or IDHC? Diaceutics has a beta of 0.92, meaning that its stock price is 8% less volatile than the broader market. Comparatively, Integrated Diagnostics has a beta of 0.355, meaning that its stock price is 65% less volatile than the broader market. SummaryIntegrated Diagnostics beats Diaceutics on 8 of the 14 factors compared between the two stocks.How does Integrated Diagnostics compare to Abingdon Health?Abingdon Health (LON:ABDX) and Integrated Diagnostics (LON:IDHC) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, analyst recommendations, institutional ownership, risk, earnings, valuation and dividends. Is ABDX or IDHC more profitable? Integrated Diagnostics has a net margin of 17.46% compared to Abingdon Health's net margin of -33.88%. Integrated Diagnostics' return on equity of 42.26% beat Abingdon Health's return on equity.Company Net Margins Return on Equity Return on Assets Abingdon Health-33.88% -55.91% -17.93% Integrated Diagnostics 17.46%42.26%9.69% Does the media favor ABDX or IDHC? In the previous week, Abingdon Health's average media sentiment score of 0.00 equaled Integrated Diagnostics'average media sentiment score. Company Overall Sentiment Abingdon Health Neutral Integrated Diagnostics Neutral Which has preferable valuation and earnings, ABDX or IDHC? Integrated Diagnostics has higher revenue and earnings than Abingdon Health. Abingdon Health is trading at a lower price-to-earnings ratio than Integrated Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAbingdon Health£9.57M2.89-£796.37K-£0.81N/AIntegrated Diagnostics£8.35B0.00£4.01T£217.000.00 Which has more volatility and risk, ABDX or IDHC? Abingdon Health has a beta of 0.117, suggesting that its stock price is 88% less volatile than the broader market. Comparatively, Integrated Diagnostics has a beta of 0.355, suggesting that its stock price is 65% less volatile than the broader market. Do institutionals & insiders hold more shares of ABDX or IDHC? 3.7% of Abingdon Health shares are held by institutional investors. Comparatively, 7.7% of Integrated Diagnostics shares are held by institutional investors. 8.0% of Abingdon Health shares are held by insiders. Comparatively, 28.0% of Integrated Diagnostics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummaryIntegrated Diagnostics beats Abingdon Health on 10 of the 11 factors compared between the two stocks.How does Integrated Diagnostics compare to genedrive?genedrive (LON:GDR) and Integrated Diagnostics (LON:IDHC) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, media sentiment, valuation, earnings, analyst recommendations, risk and profitability. Which has more volatility & risk, GDR or IDHC? genedrive has a beta of -0.04, meaning that its stock price is 104% less volatile than the broader market. Comparatively, Integrated Diagnostics has a beta of 0.355, meaning that its stock price is 65% less volatile than the broader market. Does the media prefer GDR or IDHC? In the previous week, genedrive's average media sentiment score of 0.00 equaled Integrated Diagnostics'average media sentiment score. Company Overall Sentiment genedrive Neutral Integrated Diagnostics Neutral Which has preferable valuation & earnings, GDR or IDHC? Integrated Diagnostics has higher revenue and earnings than genedrive. genedrive is trading at a lower price-to-earnings ratio than Integrated Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratiogenedrive£929K19.79-£21.22M-£0.79N/AIntegrated Diagnostics£8.35B0.00£4.01T£217.000.00 Do insiders & institutionals believe in GDR or IDHC? 0.1% of genedrive shares are owned by institutional investors. Comparatively, 7.7% of Integrated Diagnostics shares are owned by institutional investors. 4.9% of genedrive shares are owned by company insiders. Comparatively, 28.0% of Integrated Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Is GDR or IDHC more profitable? Integrated Diagnostics has a net margin of 17.46% compared to genedrive's net margin of -500.75%. Integrated Diagnostics' return on equity of 42.26% beat genedrive's return on equity.Company Net Margins Return on Equity Return on Assets genedrive-500.75% -1,044.57% -74.09% Integrated Diagnostics 17.46%42.26%9.69% SummaryIntegrated Diagnostics beats genedrive on 10 of the 11 factors compared between the two stocks.How does Integrated Diagnostics compare to Yourgene Health?Yourgene Health (LON:YGEN) and Integrated Diagnostics (LON:IDHC) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, earnings, analyst recommendations, media sentiment, institutional ownership, dividends, valuation and risk. Does the media favor YGEN or IDHC? In the previous week, Yourgene Health had 1 more articles in the media than Integrated Diagnostics. MarketBeat recorded 1 mentions for Yourgene Health and 0 mentions for Integrated Diagnostics. Yourgene Health's average media sentiment score of 0.00 equaled Integrated Diagnostics'average media sentiment score. Company Overall Sentiment Yourgene Health Neutral Integrated Diagnostics Neutral Which has stronger valuation and earnings, YGEN or IDHC? Integrated Diagnostics has higher revenue and earnings than Yourgene Health. Yourgene Health is trading at a lower price-to-earnings ratio than Integrated Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioYourgene Health£29.67M0.00-£8.17M-£0.01N/AIntegrated Diagnostics£8.35B0.00£4.01T£217.000.00 Which has more volatility & risk, YGEN or IDHC? Yourgene Health has a beta of 0.86, indicating that its stock price is 14% less volatile than the broader market. Comparatively, Integrated Diagnostics has a beta of 0.355, indicating that its stock price is 65% less volatile than the broader market. Is YGEN or IDHC more profitable? Integrated Diagnostics has a net margin of 17.46% compared to Yourgene Health's net margin of -27.55%. Integrated Diagnostics' return on equity of 42.26% beat Yourgene Health's return on equity.Company Net Margins Return on Equity Return on Assets Yourgene Health-27.55% -27.06% -6.71% Integrated Diagnostics 17.46%42.26%9.69% Do institutionals and insiders have more ownership in YGEN or IDHC? 23.3% of Yourgene Health shares are owned by institutional investors. Comparatively, 7.7% of Integrated Diagnostics shares are owned by institutional investors. 64.4% of Yourgene Health shares are owned by company insiders. Comparatively, 28.0% of Integrated Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. SummaryIntegrated Diagnostics beats Yourgene Health on 7 of the 11 factors compared between the two stocks.How does Integrated Diagnostics compare to ANGLE?ANGLE (LON:AGL) and Integrated Diagnostics (LON:IDHC) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, earnings, profitability and analyst recommendations. Which has more risk and volatility, AGL or IDHC? ANGLE has a beta of 0.22, suggesting that its stock price is 78% less volatile than the broader market. Comparatively, Integrated Diagnostics has a beta of 0.355, suggesting that its stock price is 65% less volatile than the broader market. Do insiders and institutionals have more ownership in AGL or IDHC? 17.5% of ANGLE shares are held by institutional investors. Comparatively, 7.7% of Integrated Diagnostics shares are held by institutional investors. 2.7% of ANGLE shares are held by company insiders. Comparatively, 28.0% of Integrated Diagnostics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the media refer more to AGL or IDHC? In the previous week, ANGLE had 1 more articles in the media than Integrated Diagnostics. MarketBeat recorded 1 mentions for ANGLE and 0 mentions for Integrated Diagnostics. Integrated Diagnostics' average media sentiment score of 0.00 beat ANGLE's score of -0.49 indicating that Integrated Diagnostics is being referred to more favorably in the news media. Company Overall Sentiment ANGLE Neutral Integrated Diagnostics Neutral Is AGL or IDHC more profitable? Integrated Diagnostics has a net margin of 17.46% compared to ANGLE's net margin of -732.40%. Integrated Diagnostics' return on equity of 42.26% beat ANGLE's return on equity.Company Net Margins Return on Equity Return on Assets ANGLE-732.40% -89.82% -29.89% Integrated Diagnostics 17.46%42.26%9.69% Which has preferable earnings & valuation, AGL or IDHC? Integrated Diagnostics has higher revenue and earnings than ANGLE. ANGLE is trading at a lower price-to-earnings ratio than Integrated Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioANGLE£2.62M2.89-£21.76M-£4.80N/AIntegrated Diagnostics£8.35B0.00£4.01T£217.000.00 SummaryIntegrated Diagnostics beats ANGLE on 10 of the 13 factors compared between the two stocks. Get Integrated Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for IDHC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IDHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IDHC vs. The Competition ExportMetricIntegrated DiagnosticsDiagnostics & Research IndustryMedical SectorLON ExchangeMarket Cap£341.82M£67.56M£6.38B£3.03BDividend Yield1.45%3.28%2.76%6.10%P/E Ratio0.000.7921.02365.89Price / Sales0.00620.24557.9587,843.39Price / CashN/A11.4244.5727.89Price / Book0.003.4210.377.69Net Income£4.01T£334.07B£3.56B£5.89B7 Day Performance6.93%-3.29%5.11%8.05%1 Month Performance-5.79%-2.48%3.59%2.82%1 Year Performance60.99%8.69%34.19%77.61% Integrated Diagnostics Competitors List ExportCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IDHCIntegrated DiagnosticsN/AGBX 0.59-0.3%N/A+63.7%£341.82M£8.35B0.006,692DXRXDiaceuticsN/AGBX 167-0.7%GBX 193.33+15.8%+17.9%£141.33M£34.40MN/A151ABDXAbingdon HealthN/AGBX 11.75+2.2%N/A+79.3%£29.50M£9.57MN/A84Gap UpGDRgenedriveN/AGBX 1.10-4.3%N/A-14.9%£17.66M£929KN/A43YGENYourgene HealthN/AN/AN/AN/A£16.43M£29.67MN/A253 Related Companies and Tools Related Companies DXRX Alternatives ABDX Alternatives GDR Alternatives YGEN Alternatives AGL Alternatives GENI Alternatives VRCI Alternatives PRM Alternatives DMTR Alternatives LLAI Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:IDHC) was last updated on 5/23/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredThe AI stocks about to become worthless (and one that isn't)Louis Navellier - who manages $1.1 billion including $358 million in AI stocks - says a new AI computer being ...InvestorPlace | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Integrated Diagnostics Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Integrated Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
